US Supreme Court weighs use of prescriber data for pharma marketing
This article was originally published in SRA
Executive Summary
Although the US tax season ended more than a week ago, the topic seemed to linger on the minds of the Supreme Court justices during oral arguments on 26 April about the constitutionality of a Vermont law that restricts the sale or use of prescription data for marketing purposes1.